Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00177580
Status:
COMPLETED
Last Update Posted:
2008-01-15
First Post:
2005-09-13
Brief Title:
Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With Pravastatin
Sponsor:
University of Pittsburgh
Organization:
University of Pittsburgh
Study Overview
Official Title:
A Randomized Double-Blind Placebo-Controlled Clinical Trial of Adjunctive Treatment With Pravastatin in Partially Remitted Patients With Schizophrenia or Schizoaffective Disorder
Status:
COMPLETED
Status Verified Date:
2008-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study supplements patients current medications with Pravastatin a cholesterol-lowering medication to try to improve residual symptoms of schizophrenia and also to improve cognitive functioning
Detailed Description:
This study supplements patients current medications with Pravastatin a cholesterol-lowering medication to try to improve residual symptoms and also to improve cognitive functioning It consists of 15 total study visits over a 28-week period of time one visit every 2 weeks
Blood draws will be done once every 4 weeks throughout the study to monitor lipid levels C-Reactive protein AST ALT and CPK Total Cognitive testing will be completed at the beginning of the study and at the end of the study During the study visits the staff will be monitoring vitals signs weight height blood pressure pulse waisthip ratio possible side effects positive and negative symptoms mood symptoms and overall functioning
Blood draws will be done once every 4 weeks throughout the study to monitor lipid levels C-Reactive protein AST ALT and CPK Total Cognitive testing will be completed at the beginning of the study and at the end of the study During the study visits the staff will be monitoring vitals signs weight height blood pressure pulse waisthip ratio possible side effects positive and negative symptoms mood symptoms and overall functioning
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None